Reduction of Cancer Risk with an Oral Supplement of Selenium

Biomedical and Environmental Sciences

Volumn 10, Issue 2-3, 1997, Pages 227-234

  Combs Jr , G F ^a   Clark, L C ^b   Turnbull, B W ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SELENIUM;

ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH SURVEY; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; UNITED STATES;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLACEBOS; POPULATION SURVEILLANCE; SELENIUM; SKIN NEOPLASMS; UNITED STATES;

EID: 0031225596     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Blot, W. J., Li, J. Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G. Q., Yang, C. S., Zheng, S. F., Gail, M., Li, G. Y., Liu, B, Q., Tangrea, J., Sun, Y. H., Liu, F., Fraumeni Jr., F., Zhang, Y. H., and Li, B. (1993). Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidencne, and disease-specific mortality in the general population. J. Nat. Cancer Inst. 85, 1483-1292.
2. Clark, L. C., Combs, Jr., G. F., Turnbull, B. W., Slate, E., Alberts, D., Abele, D., Allison, R., Bradshaw, J., Chalker, D., Chow, J., Curtis, D., Dalen, J., Davis, L., Deal, R., Dellasega, M., Glover, R., Graham, G., Gross, E., Hendrix, J., Herlong, J., Knight, F., Krongrad, A., Lesher, J., Moore, J., Park, K., Rice, J., Rogers, A., Sanders, B., Schurman, B., Smith, C., Smith, E., andTaylor, J. (1996). The nutritional prevention of cancer with selenium 1983-1993: a Randomized Clinical Trial. J. Am. Med. Assoc. 276, 1957-1963.
3. Clark, L. C., Cantor, K. P., and Allaway, W. H. (1991). Selenium in forage crops and cancer mortality in U. S. counties. Arch. Environ. Health 46, 37-43.
4. Clark, L. C., Graham, G. F., Crounse, R. G., Grimson, R., Hulka, B., and Shy, C. M. (1984). Plasma selenium and skin neoplasms: A case-control study. Nutr. Cancer 6, 13-19.
5. Combs, Jr., G. F. (1994). Essentiality and Toxicity of Selenium: a Critique of the Recommended Dietary Allowance and the Reference Dose. In Risk Assessment of Essential Elements (W. Mertz, C. Abernathy, and S. Olin, Eds.), 167-183. ILSI Press, Washington, D. C.
6. Combs, Jr., G. F. (1997). Selenium and Cancer, In Antioxidants and Disease Prevention (H. Garewal, Ed.), pp. 97-113. CRC Press, New York.
7. El-Bayoumy, K. (1991). The role of selenium in cancer prevention. In Practice of Oncology, 4th ed. (V. DeVita, S. Hellman, and S. Rosenberg, Eds.), pp. 1-15. Lippincott, Philadelphia.
8. Garland, M., Morris, J. S., Stamfer, M. J., Colditz, G. A., Spate, V. L., Baskett, C. K., Rosner, B., Sperizer, F. E., Willett, W. C., and Hunter, D. J. (1995). Prospective study of toenail selenium and cancer among women. J. Nat. Cancer Inst. 87, 497-505.
9. Ip, C. (1986). Selenium and experimental carcinogenesis. Ann. Clin. Res. 18, 22-29.
10. Ip, C and Medina, D. (1987). Current concept of selenium and mammary tumorigenesis. In Cellular and Molecular Biology of Breast Cancer (D. Medina, W. Kidwell, G. Heppner, 4nd E. Anderson, Eds.), pp. 479. Plenum Press, New York.
11. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Teppo, L., and Hakama, M. (1988) Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int. J. Cancer 42, 846-850.
12. Kok, F. J., DeBruijn, A. M., Hofman, A., Vermeeren, R., and Valkenburg, H. A. (1987). Is serum selenium a risk factor for cancer in men only? Am . J. Epidemiol. 125, 12-16.
13. Menkes, M. S., Comstock, G. W., Vuilleumier, J. P., Helsing, K. J., Rider, A. A., and Brookmeyer, R. P. (1986). Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. New Engl. J. Med. 315, 1250-1254.
14. Milner, J. A. (1985). Effect of selenium on virally induced and transplantable tumor models. Fed. Proc. 44, 2568-2572.
15. Nomura, A., Heilbrun, L. K., Morris, J. S., and Stemmermann, G. N. (1987). Serum selenium and the risk of cancer, by specific sites: Case-control analysis of prospective data. J. Nat. Cancer Inst. 79, 103-108.
16. Olson, O. E., Palmer, I. S., and Cary, E. E. (1975). Modification of the official fluorometric method for selenium in plants. J. Assoc. Off. Anal. Chem. 58, 117-126.
17. Pelag, I., Morris, S., and Hames, C. G. (1985). Is serum selenium a risk factor for cancer? Med. Oncol. Tumor Pharmacother. 2, 137-142.
18. Ringstad, J., Jacobsen, B. K., Tretli, S., and Thomassen, Y. (1988). Serum selenium concentration associated with risk of cancer. J. Clin. Patkol. 41, 454-457.
19. Salonen, J. T., Alfthan, G., Huttunen, J. K., and Puska, P. (1984). Association between serum selenium and the risk of cancer. Am. J. Epidemiol, 120, 342-346.
20. Salonen, J. T., Salonen, R., Lappeteläinen, R., Mäenpää, P. H., Alfthan, G., and Puska, P. (1985). Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br. Med. J. 290, 417-420.
21. Schober, S. E., Comstock, G. W., Helsing, K. J., Salkeld, R. M., Morris, J. S., Rider, A. A., and Brookmeyer, R. (1987). Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am. J. Epidemiol. 126, 1033-1041.
22. Shamberger, R. J. and Frost, D. V. (1969). Possible protective effect of selenium against human cancer. Can. Med. Assn. J. 104, 682.
23. Shamberger, R. J. and Willis, C. E. (1971). Selenium distribution of human cancer mortality. CRC Crit. Rev. Clin. Lab Sci. 2, 211-219.
24. van den Brandt, P., Goldbohm, R., van't Veer, P., Bode, P., dorant, E., Hermus, R., and Sturmans, F. (1993). A prospective cohort study of toenail selenium levels and risk of gastrointestinal cancer. J. Nat. Cancer Inst. 85, 224-229.
25. Virtamo, J., Valkeila, E., Alfthan, G., Punsar, S., Huttunen, J. K., and Karvonen, M. J. (1987). Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer 60, 145-148.
26. Willett, W., Polk, B., Morris, S., Stampfer, M., Preissel, S., Rosner, B., Taylor, J., Schneider, K., and Hames, C. (1983). Prediagnostic serum selenium and risk of cancer. Lancet 2, 130-134.